TVAMP
AZN icon

Tennessee Valley Asset Management Partners’s AstraZeneca AZN Stock Holding History

Tennessee Valley Asset Management Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-17
Closed -$2.29K – 167
2023
Q4 		$2.29K Buy
+17
New +$2.21K ﹤0.01% 646

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Tennessee Valley Asset Management Partners's AZN Position: Q1 2024 in Review

Tennessee Valley Asset Management Partners sold out of AstraZeneca (AZN) in Q1 2024, closing a stake of 17 shares — an estimated $2.29K sold.

Tennessee Valley Asset Management Partners first reported a position in AZN in Q4 2023 and held it in 1 quarter. The position peaked at $2.29K in Q4 2023. 1,142 funds tracked by Wall St. Rank hold AZN as of Q1 2024.

  • Tennessee Valley Asset Management Partners reported no remaining AstraZeneca position as of Q1 2024 after selling out during the quarter.
  • Tennessee Valley Asset Management Partners sold 17 AstraZeneca shares in Q1 2024, an estimated $2.29K.
  • Tennessee Valley Asset Management Partners first reported a position in AstraZeneca in Q4 2023 and held it in 1 quarter.
  • Tennessee Valley Asset Management Partners's AstraZeneca position peaked at $2.29K in Q4 2023.
  • 1,142 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2024.

Based on Tennessee Valley Asset Management Partners's 13F filing for Q1 2024, filed 23 Apr 2024.